BIOVIT — Bio Vitos Pharma AB Balance Sheet
0.000.00%
- SEK5.33m
- SEK5.31m
- SEK0.41m
Annual balance sheet for Bio Vitos Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 6.37 | 8.79 | 3.19 | 3.07 | 0.021 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.693 | 0.494 | 0.786 | 1.13 | 0.44 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8.29 | 11.1 | 5.22 | 5.11 | 0.668 |
Net Property, Plant And Equipment | 2.3 | 1.84 | 1.32 | 0.806 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 35.8 | 35.5 | 26.4 | 33.9 | 16.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.26 | 1.96 | 1.53 | 1.01 | 0.479 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.26 | 1.96 | 1.53 | 1.01 | 0.479 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 33.5 | 33.5 | 24.9 | 32.9 | 16.1 |
Total Liabilities & Shareholders' Equity | 35.8 | 35.5 | 26.4 | 33.9 | 16.6 |
Total Common Shares Outstanding |